SIGA Technologies Target of Unusually High Options Trading (NASDAQ:SIGA)

SIGA Technologies, Inc. (NASDAQ:SIGA) saw some unusual options trading activity on Wednesday. Stock traders acquired 1,200 call options on the stock. This represents an increase of approximately 1,438% compared to the typical volume of 78 call options.

Institutional Investors Weigh In On SIGA Technologies

A number of hedge funds have recently made changes to their positions in the business. Wellington Management Group LLP bought a new stake in SIGA Technologies in the 3rd quarter valued at about $757,000. Hotchkis & Wiley Capital Management LLC raised its stake in SIGA Technologies by 152.6% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 2,048,440 shares of the company’s stock valued at $13,827,000 after acquiring an additional 1,237,620 shares during the period. Foundry Partners LLC bought a new stake in shares of SIGA Technologies during the third quarter valued at about $2,801,000. Harbor Capital Advisors Inc. bought a new stake in shares of SIGA Technologies during the third quarter valued at about $1,098,000. Finally, Allspring Global Investments Holdings LLC increased its position in shares of SIGA Technologies by 172.1% during the third quarter. Allspring Global Investments Holdings LLC now owns 211,236 shares of the company’s stock valued at $1,426,000 after buying an additional 133,597 shares during the period. 55.40% of the stock is currently owned by institutional investors.

SIGA Technologies Trading Up 1.3 %

NASDAQ SIGA opened at $6.47 on Friday. The company has a fifty day simple moving average of $6.37 and a 200 day simple moving average of $7.53. SIGA Technologies has a 12-month low of $4.26 and a 12-month high of $12.83. The company has a market cap of $461.96 million, a P/E ratio of 5.39 and a beta of 0.94.

SIGA Technologies (NASDAQ:SIGA) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.02 earnings per share (EPS) for the quarter. The firm had revenue of $10.01 million for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%. Sell-side analysts predict that SIGA Technologies will post 1.04 EPS for the current year.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.